 |
 |
 |
Search IPO GMP:
Speciality Medicines IPO GMP
Speciality Medicines IPO is an SME IPO, the company will raise up to 29 crore 14 lakh rupees for 23,50,000 shares. The IPO comprises a fresh issue of 23,50,000 shares (aggregating up to 29 crore 14 lakh rupees), and an offer for sale (OFS) of NIL.
| Speciality Medicines IPO GMP (Grey Market Premium) | |
| Premium From IPO Cut-off Price | |
| IPO Price Band | ₹117 to ₹124 per share |
Speciality Medicines IPO Latest GMP (Grey Market Premium) Today
Visit us daily to get the latest update on IPO GMP. You will get the latest update of SME IPO GMP.
Speciality Medicines IPO Lates GMP (grey market premium) available here
- Price Band of Speciality Medicines IPO is ₹117 to ₹124 per share.
- Current GMP (Grey Market Premium) for Speciality Medicines IPO is:
- It is a premium for the IPO cut-off price .
- As per Speciality Medicines IPO Taday’s GMP Data, the estimated listing price of Speciality Medicines IPO shares can be:
- Estimated listing price calculated as Speciality Medicines IPO cutoff price or allotment price: ₹124 per share + IPO current GMP: .
Speciality Medicines SME IPO GMP |
||
| Date | GMP (₹) | Listing Price (₹-Estimated) |
| Today | 0 | |
| 27 March 2025 | 0 | |
| 26 March 2025 | 0 | |
| 25 March 2025 | 0 | |
| 24 March 2025 | 0 | |
| 23 March 2025 | 0 | |
| 22 March 2025 | 0 | |
| 21 March 2025 | 0 | |
| 20 March 2025 | 0 | |
| 19 March 2025 | 0 | |
| 18 March 2025 | 0 | |
Total shares offered by Speciality Medicines IPO is 23,50,000 shares (aggregating up to 29 crore 14 lakh rupees). Out of which 10,90,000 shares (46.38%) is reserved for retail, 10,89,000 shares (46.34%) is reserved for HNI (NII), 21,000 shares (0.89%) is reserved for QIB, and 1,50,000 shares (6.38%) is reserved for market maker Aikyam Capital Private Limited.
Speciality Medicines IPO will open for subscription on 20 March 2026 and close on 24 March 2026. Basis of allotment will be decided on 25 March 2026, initiation of refund will begin on 27 March 2026 and finally IPO will be listed on 30 March 2026 at BSE SME. Unistone Capital Pvt Ltd is the book running lead manager and Skyline Financial Services Pvt Ltd is the registrar of the Speciality Medicines IPO.
Speciality Medicines IPO Price Band and Market Lot
Speciality Medicines has set a price band of ₹117 to ₹124 per share and lot size is of 1000. Retail investors can bid for a minimum and maximum of 2 lots (2,000 shares), requiring an investment of ₹2,48,000, sHNI investors can bid for a minimum of 3 lots (3,000 shares), requiring an investment of ₹3,72,000 and bHNI investors can bid for a minimum of 9 Lots (9,000 shares), requiring an investment of ₹11,16,000 calculated at the cut-off price ₹124 per share (the upper end of the price band).
| Speciality Medicines IPO Price | |
| Face Value | ₹10 per share |
| Price Band | ₹117 to ₹124 per share |
| Lot Size | 1,000 shares |
| IPO Issue Type | Book Built Issue |
About Speciality Medicines
Incorporated in 2021, headquarterd in Mumbai, Speciality Medicines Limited is a pharmaceutical company specializing in the marketing, distribution, wholesaling, trading, and exporting of high value specialty formulations. It focuses on treatments for complex chronic conditions across oncology, immunology, neurology, cardiology, anti virals, hepatitis, antifungals, and rare diseases, offering over 650 products including capsules, injections, infusions, creams, inhalers, vaccines, and plasma productsSpeciality Medicines IPO GMP FAQs
The latest Grey Market Premium (GMP) of Speciality Medicines IPO is .
It is a premium to the IPO cut-off price Speciality Medicines. GMP gives a rough estimate of the premium at which the stock might list. It’s not guaranteed but often aligns with market sentiment.
As per latest GMP data, the expected return for Speciality Medicines IPO can be .
Expected listing listing price for Speciality Medicines share can be .
According to latest GMP data pattern expected listing price and profit per share for Speciality Medicines IPO can be . Expected listing price is calculated by adding the GMP to the IPO issue price. Estimated listing price = IPO issue price + current GMP. This value changes as the GMP fluctuates.
GMP is an unofficial indicator and can be manipulated. It should never be the sole reason to apply. Always consider fundamentals and risk tolerance. Subscription demand, financial performance, market sentiment, peer valuation, and overall liquidity can impact the GMP trend.
Disclaimer:
- Grey market premium (GMP) indicates investors are willing to pay more than the issue price.
- A negative GMP suggests that the IPO’s share is likely to be listed on the stock exchange at a discount, and a positive Grey Market Premium suggests that the IPO’s share is likely to be listed on the stock exchange at a profit.
- Do not subscribe for IPO by just seeing the premium Price, It can change anytime
- We do not trade/deal or buy/sell IPO forms in the grey market and GMP prices shown here are gathered from various sources.